GI Oncology
Conference Coverage
A methylene blue dye pill sheds light on hard-to-see polyps
Polyps can go unseen during colorectal cancer screenings. But a new dye pill may help in identifying flat and subtle polyps and stop cancer in its...
Conference Coverage
New ‘immune checkpoint’ vaccine shows promise in treating colorectal cancer
A vaccine may be a future treatment of colorectal cancer and is currently in phase 1 human trials.
From the Journals
CRC recurrence surveillance studies: No benefit to high-intensity strategy
More frequent follow-up with computed tomography of the thorax and abdomen and serum carcinoembyronic antigen (CEA) testing does not significantly...
From the Journals
Patients with CF at increased risk for GI cancers
Patients who received lung transplants for cystic fibrosis are at especially high risk for developing gastrointestinal cancers.
Conference Coverage
New drugs provide new options in HCC
PHILADELPHIA – “We are on the cusp where new compounds not only are being tested, but they are being approved.”
Conference Coverage
Hepatic adenoma assessment: Wait longer to avoid overtreatment?
LAS VEGAS – In women it may take longer after oral contraceptive withdrawal than currently recommended for hepatic adenomas to regress.
In Focus
Underserved populations and colorectal cancer screening: Patient perceptions of barriers to care and effective interventions
Minority populations born in the United States and immigrant populations are among those with the lowest rates of CRC screening.
From the Journals
Single screening for Lynch syndrome beats sequential tests in CRC
Tumor sequencing is more accurate and might be faster than some existing protocols too.
From the Journals
Sessile serrated colon polyps may be detectable noninvasively
Sessile serrated polyps of the colon bear a distinct DNA methylation signature that may allow early cancer detection from stool samples.
From the Journals
Survival worse with alcohol-related HCC, compared with other types
Patients with alcohol-related hepatocellular carcinoma have worse overall survival, likely because of delays in diagnosis and later stage at...